瘤透细胞的复杂相互作用在驱动治疗耐药性途径中的作用
Dengxiong Li1, Fanglin Shao2, Qingxin Yu3,4
1Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Cell communication and signaling : CCS
|August 19, 2024
概括
向瘤微环境 (TME) 可以克服癌症药物耐药性. 了解透细胞以及炎症和新陈代谢等因素是开发新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 耐药性是癌症治疗的一个主要障碍.
- 瘤微环境 (TME) 在中介抵抗方面发挥着关键作用.
- 癌细胞和树皮细胞之间的相互作用会影响治疗结果.
研究的目的:
- 审查当前关于TME内透细胞及其在药物耐药性中的作用的研究.
- 探索导致药物耐药性的因素,如炎症,新陈代谢,衰老,缺氧和血管生成.
- 评估针对TME作为克服癌症治疗耐药性的战略的潜力.
主要方法:
- 文献综述综合了当前的研究成果.
- 对研究TME中的细胞相互作用的研究进行分析.
- 检查分子机制,包括STAT3过度表达,涉及药物耐药性.
主要成果:
- 通过各种细胞和分子机制,TME显著影响癌症药物耐药性.
- 诸如炎症,新陈代谢变化,衰老,缺氧和血管生成等因素有助于抵抗.
- 在耐药癌症和树皮细胞中经常观察到STAT3的过度表达.
结论:
- 准TME是一个有希望的策略来打击癌症药物耐药性.
- 需要进行进一步的研究,以提高理解树皮细胞贡献的特异性和统计学稳定性.
- 高质量的证据对于验证TME向治疗至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


